Helios Universitaetsklinikum Wuppertal — Clinical Trial Site

71 Registered trials

39 Currently recruiting

Organisation

Helios Universitaetsklinikum Wuppertal

Location

Wuppertal, Germany

Identifier

ORG-100033534

Address

Heusnerstrasse 40, Barmen, 42283, Germany

Departments

-
"Center for Clinical Research at the Philipp Klee Institute for Clinical Pharmacology "
#2607: Zentrum für Dermatologie, Allergologie und Dermatochirurgie
049001_Kinder-und Jugendmedizin
04901
1009 : Klinik fuer Nuklearmedizin
2311: Klinik für Kardiologie / HKF
Breast Cancer Unit
Breast Center
Breast Center and Department of Senology
Brustzentrum
Campus Barmen
Center for Dermatology, Allergology and Dermatosurgery
Department of Dermatology, Allergology and Dermatosurgery
Department of Hematology, Oncology, Clinical Infectology and Palliative Medicine
Dermatologie
Dermatology
Gynäkologie, Senologie
Gynäkologie/Senologie
Gynecology and obstetric
Haematology, oncology, clinical infectiology and palliative medicine
Hämatologie, Onkologie, klinische Infektiologie und Palliativmedizin
Helios Klinikum Wuppertal Landesfrauenklinik
Helios Universitätsklinikum Wuppertal
Hematology
Hematology, Oncology and palliative medicine
Hematology, Oncology, Clinical Infectiology and Palliative Medicine
Kardiologie
Klinik für Allgemein- und Viszeralchirurgie
Klinik für Dermatologie
Klinik für Haematologie, Onkologie und Palliativmedizin
Klinik für Hämatologie, Onkologie und Palliativmedizin
Klinik für Hämatologie, Onkologie, klinische Infektiologie und Palliativmedizin
Klinik für Kinder- und Jugendmedizin
Klinik für Urologie und Kinderurologie
Klinik und Poliklinik für Dermatologie und Allergologie
Landesfrauenklinik
Landesfrauenklinik - Brustzentrum
Medical Clinic I Haematology, Nephrology, Oncology and Palliative Medicine
Medical oncology
Medizinische Klinik 1 Hämatologie / Onkologie
Medizinische Klinik 3
MEDIZINISCHE KLINIK I
Medizinische Klinik I, Haematologie/Onkologie
N.A.
N/A
NA
Oncology
Onkologie
Onkologisches Zentrum
Senologie
Senology
Zentrum für Dermatologie, Allergologie und Dermatochirurgie
Zentrum für Kinder - und Jugendmedizin
Zentrum für Kinder- und Jugendmedizin
Zentrums für Dermatologie, Allergologie und Dermatochirurgie

Clinical trials at this site (71)

Search interface

Trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to standard therapy versus standard therapy in patients… Ended

2022-500237-92-00 Newly-diagnosed high-intermediate and high-risk diffuse 5 2021-04-23
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Study with apalutamide in patients with prostate cancer in whom the prostate has been removed who are at high risk of disease recurrence Ended

2024-511832-29-00 High risk adenocarcinoma of the prostate after radical 4 2020-08-05
A randomized, controlled, open-label, phase III-trial on Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing abemaciclib combi… Ended

2023-509242-35-00 HR+/HER2- early breast cancer 5 2020-07-23
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
Open-Label, Single Arm Phase II Trial Investigating the Efficacy, Safety and Quality of Life of Neoadjuvant Chemotherapy with Liposomal Irin… Halted

2024-512951-18-00 Hepatic Oligometastatic Adenocarcinoma of the Pancreas 4 2021-08-06
A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe … Ended

2024-511360-87-00 hidradenitis suppurativa (HS) 5 2024-10-02
A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherap… Ended

2022-502653-34-01 Atopic dermatitis and moderate-to severe atopic hand ec 11 2024-05-30
A Study to Investigate Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age with Moder… Ended

2022-502183-20-00 Moderately to Severely Active Ulcerative Colitis 5 2024-02-26
A Window-of-Opportunity study of hormone therapy in premenopausal women with ER-positive/HER2-negative early breast cancer. Ended

2022-503013-32-00 ER-positive/HER2-negative early breast cancer 4 2024-01-29
Functional Constipation: A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Le… Ended

2022-501947-34-00 Functional Constipation (FC) 4 2023-12-05
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon) Ended

2022-501538-44-00 Atopic Dermatitis 5 2023-04-25
Interventional Platform Study Investigating the Impact of Digital Health Solutions on Health Outcomes and Health-Care Resource Utilization i… Ended

2023-504342-55-00 Cohort A: • Metastatic non-small cell lung carcinoma ( 10 2023-02-02
Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus I… Ended

2024-511755-18-00 Invasive Candidiasis/ Candidemia 5 2022-12-23
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
Study to investigate the efficacy and safety of allo-APZ2-CVU on wound healing of therapy-resistant chronic venous ulcer (CVU) Ended

2023-510162-27-00 Chronic venous ulcers (CVU) 4 2021-08-18
Polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) versus R-ICE alone in second line treatment of diffus… Ended

2023-508259-38-00 Adult patients with relapsed or primary refractory DLBC 5 2021-04-29
Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Chemotherapy plus Paclitaxel and Bevacizumab in Carcinoma of the Cervi… Ended

2024-514179-17-00 Metastatic (stage IVB), Persistent, or Recurrent Carcin 5 2018-10-02
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15